Protagenic Therapeutics, Inc. (PTIX)
0.46
-0.01
(-2.52%)
USD |
OTCM |
Nov 13, 16:00
Protagenic Therapeutics Market Cap : 0.8327M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 0.8327M |
| November 12, 2026 | 0.8542M |
| November 11, 2026 | 0.8763M |
| November 10, 2026 | 0.8932M |
| November 09, 2026 | 0.9826M |
| November 06, 2026 | 0.9775M |
| November 05, 2026 | 1.140M |
| November 04, 2026 | 1.140M |
| November 03, 2026 | 1.177M |
| November 02, 2026 | 1.122M |
| October 30, 2026 | 1.155M |
| October 29, 2026 | 1.169M |
| October 28, 2026 | 1.183M |
| October 27, 2026 | 1.183M |
| October 26, 2026 | 1.173M |
| October 23, 2026 | 1.303M |
| October 22, 2026 | 1.330M |
| October 21, 2026 | 1.303M |
| October 20, 2026 | 1.358M |
| October 19, 2026 | 1.358M |
| October 16, 2026 | 1.358M |
| October 15, 2026 | 1.358M |
| October 14, 2026 | 1.448M |
| October 13, 2026 | 1.459M |
| October 12, 2026 | 1.459M |
| Date | Value |
|---|---|
| October 09, 2026 | 1.394M |
| October 08, 2026 | 1.394M |
| October 07, 2026 | 1.394M |
| October 06, 2026 | 1.394M |
| October 05, 2026 | 1.401M |
| October 02, 2026 | 1.401M |
| October 01, 2026 | 1.412M |
| September 30, 2026 | 1.466M |
| September 29, 2026 | 1.462M |
| September 28, 2026 | 1.412M |
| September 25, 2026 | 1.401M |
| September 24, 2026 | 1.478M |
| September 23, 2026 | 1.557M |
| September 22, 2026 | 1.557M |
| September 21, 2026 | 1.64M |
| September 18, 2026 | 1.655M |
| September 17, 2026 | 1.319M |
| September 16, 2026 | 1.521M |
| September 15, 2026 | 1.430M |
| September 14, 2026 | 1.502M |
| September 11, 2026 | 1.577M |
| September 10, 2026 | 1.577M |
| September 09, 2026 | 1.665M |
| September 08, 2026 | 1.857M |
| September 04, 2026 | 1.919M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 46.12M |
| Sangamo Therapeutics, Inc. | 48.47M |
| Sarepta Therapeutics, Inc. | 1.723B |
| Anixa Biosciences, Inc. | 90.61M |
| Vicapsys Life Sciences, Inc. | 16.19M |
Market Cap Related Metrics
| PE Ratio | 0.1508 |
| Price to Book Value | 0.7445 |
| Price | 0.46 |
| Earnings Yield | 663.1% |
| Normalized PE Ratio | 0.2057 |